What happens when AI policy meets implementation — and when what companies say about safety, governance, and responsibility meets what they actually do. Analysis from an award-winning journalist and product strategist who has worked across media, government, and technology.
A Top Clinical AI Left Europe. The FDA Eased Its US Path
OpenEvidence left the EU and UK citing AI Act requirements. In January, the FDA expanded the carveout that may keep tools like it outside US regulation.